Concepedia

Carlee Moser

CM

Statistics

Publications

48

Citations

2.9K

H-Index

23

Active since

2012

Affiliations

University of California, Los Angeles(Current)

Harvard University

University of California San Diego

University of North Carolina at Chapel Hill

Case Western Reserve University

Carlee Moser is an author at University of California, Los Angeles specializing in antiretroviral therapy, pharmacotherapy, and antiviral therapy.

ORCID

Publications per year

2012–2024

48

Publications

48

Simple Risk Model Predicts Incidence of Atrial Fibrillation in a Racially and Geographically Diverse Population: the CHARGE‐AF Consortium

Álvaro Alonso, Bouwe P. Krijthe, Thor Aspelund et al. · Journal of the American Heart Association · 2013 · 886 citations · Full text

, , +17

B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies

Moritz F. Sinner, Katherine A. Stepas, Carlee Moser et al. · EP Europace · 2014 · 176 citations · Full text

, , +14

Body Composition Changes After Initiation of Raltegravir or Protease Inhibitors: ACTG A5260s

Grace A. McComsey, Carlee Moser, Judith S. Currier et al. · Clinical Infectious Diseases · 2016 · 164 citations · Full text

, , +17

Risk Assessment for Incident Heart Failure in Individuals With Atrial Fibrillation

Renate B. Schnabel, Michiel Rienstra, Lisa Sullivan et al. · European Journal of Heart Failure · 2013 · 129 citations · Full text

, , +13

Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir

Todd T. Brown, Carlee Moser, Judith S. Currier et al. · The Journal of Infectious Diseases · 2015 · 120 citations · Full text

, , +17

1–5 of 48